UAMS Gets Contract to Continue Study of Radiation Treatment Drug

The Biomedical Advanced Research and Development Authority, or BARDA, has exercised two contract options worth about $8.7 million with the University of Arkansas for Medical Sciences to develop a treatment used in radiological or nuclear emergency situations.

Want the Full Article?

Get Unlimited Archive Access for $19.95 per Year

Readers must pay to access articles older than 15 days.
Articles newer than 15 days are not included in this offer.

Purchase Now

Already have archive access? Login to view this article.